Medeze Group PCL (BKK: MEDEZE)

Market Cap	7.16B
Revenue (ttm)	823.42M
Net Income (ttm)	295.59M
Shares Out	1.07B
EPS (ttm)	0.37
PE Ratio	18.15
Forward PE	17.92
Dividend	0.16 (2.39%)
Ex-Dividend Date	Nov 26, 2024

Volume	1,732,652
Open	6.90
Previous Close	6.80
Day's Range	6.70 - 6.90
52-Week Range	6.60 - 13.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 25, 2025

About Medeze Group PCL

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells; and research, develops, and collects data on all types of human cellular activities and medical laboratory test. In addition,...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2010
• Employees: 200
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEDEZE

Financial Performance

In 2023, Medeze Group PCL's revenue was 707.37 million, an increase of 15.59% compared to the previous year's 611.98 million. Earnings were 239.57 million, an increase of 58.96%.